Your 2027 brand plan is being built on inputs that were never designed to agree with each other.

Each of those decisions draws on a different study, commissioned at a different point in the year, by a different team, against a different question, often working from a different definition of the same segment.

None of that is negligence. It is how planning cycles work in every organization. Research gets scoped when a need appears, not when the plan needs it, and the plan arrives long after the scoping decisions were made.

The consequence is predictable and rarely named out loud. By the time the plan reaches review, the weaknesses are not in the data. Every individual input holds up. The weaknesses are in the seams between the inputs.

Where the segmentation from one study does not map cleanly onto the physician typology from another. Where the forecast assumes an adoption curve the qualitative work quietly contradicts. Where the competitive read and the demand model imply different sequencing and nobody has been asked to choose.

Those seams are exactly where a plan gets picked apart. A senior reviewer does not need to challenge your evidence. They only need to notice that two pieces of it point in different directions, and the conversation shifts from strategy to reconciliation for the rest of the meeting.

Nobody was scoped to own the seams. That work lands on one person, in the final week, without a budget line, and it decides how the plan lands.

Which seam in your 2027 plan worries you most right now?